Join
Live feed
·
INSIDERFilingvia Quantisnow
Immunome Inc. logo

Director Bienaime Jean Jacques bought $43,670 worth of shares (2,000 units at $21.84), increasing direct ownership by 5% to 38,415 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
IMNM· Immunome Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IMNM (Immunome Inc.) and more on Quantisnow.